Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Randomized, Single-blind, Active-controlled, Parallel Study to Evaluate the Safety and Pharmacokinetics of Single-Dose HYR-PB21 Versus Bupivacaine Hydrochloric Acid for Subcutaneous Injection in Healthy Participants

NCT07717086 is registered in ClinicalTrials.gov with Fruithy Holdings Limited as lead sponsor.

NCT NCT07717086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07717086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Randomized, Single-blind, Active-controlled, Parallel Study to Evaluate the Safety and Pharmacokinetics of Single-Dose HYR-PB21 Versus Bupivacaine Hydrochloric Acid for Subcutaneous Injection in Healthy Participants
Lead sponsor
Fruithy Holdings Limited
Phase
Phase 1
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
October 31, 2026
Enrollment
28 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative analgesia